Pnc Financial Services Group, Inc. Cti Biopharma Corp Transaction History

Pnc Financial Services Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$4.45 - $6.17 $1,032 - $1,431	232 Added 2.32%	10,232 $61,000
Q3 2022 Nov 10, 2022	SELL	$5.36 - $7.43 $536 - $743	-100 Reduced 0.99%	10,000 $58,000
Q2 2022 Aug 12, 2022	BUY	$3.55 - $6.27 $355 - $627	100 Added 1.0%	10,100 $60,000
Q4 2021 Feb 11, 2022	BUY	$1.44 - $2.86 $14,400 - $28,600	10,000 New	10,000 $24,000
Q1 2020 May 08, 2020	SELL	$0.69 - $1.54 $690 - $1,540	-1,000 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$1.72 - $5.24 $1,720 - $5,240	1,000 New	1,000 $0

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.